E. Grant Hoyt

1.1k total citations
27 papers, 864 citations indexed

About

E. Grant Hoyt is a scholar working on Surgery, Molecular Biology and Transplantation. According to data from OpenAlex, E. Grant Hoyt has authored 27 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 15 papers in Molecular Biology and 6 papers in Transplantation. Recurrent topics in E. Grant Hoyt's work include Transplantation: Methods and Outcomes (17 papers), RNA Interference and Gene Delivery (8 papers) and Immune Response and Inflammation (5 papers). E. Grant Hoyt is often cited by papers focused on Transplantation: Methods and Outcomes (17 papers), RNA Interference and Gene Delivery (8 papers) and Immune Response and Inflammation (5 papers). E. Grant Hoyt collaborates with scholars based in United States and Netherlands. E. Grant Hoyt's co-authors include Robert C. Robbins, Randall E. Morris, Margaret E. Billingham, Robert S. Poston, A. C. Allison, Michael P. Murphy, Elsie M. Eugui, Jeffrey D. Pollard, Victor J. Dzau and Robert Poston and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Transplantation.

In The Last Decade

E. Grant Hoyt

27 papers receiving 834 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Grant Hoyt United States 15 387 307 209 172 106 27 864
Nozomi Koyamada Japan 15 802 2.1× 182 0.6× 185 0.9× 203 1.2× 35 0.3× 35 1.1k
Rafia S. Al‐Lamki United Kingdom 17 201 0.5× 410 1.3× 109 0.5× 306 1.8× 68 0.6× 22 1.1k
G R Bicknell United Kingdom 18 287 0.7× 199 0.6× 245 1.2× 42 0.2× 39 0.4× 37 787
Kazuaki Nakajima Japan 17 448 1.2× 552 1.8× 133 0.6× 196 1.1× 163 1.5× 57 1.2k
Nepal C. Chowdhury United States 18 394 1.0× 118 0.4× 60 0.3× 330 1.9× 44 0.4× 31 816
Paul Hechenleitner Austria 10 492 1.3× 147 0.5× 119 0.6× 146 0.8× 17 0.2× 20 705
Günter Weigel Austria 13 156 0.4× 302 1.0× 74 0.4× 76 0.4× 103 1.0× 23 698
Huifang Chen China 16 217 0.6× 466 1.5× 123 0.6× 105 0.6× 26 0.2× 47 913
Hongsi Jiang United States 15 185 0.5× 242 0.8× 151 0.7× 145 0.8× 33 0.3× 43 632
S. Yamamoto Japan 13 296 0.8× 160 0.5× 78 0.4× 212 1.2× 17 0.2× 41 649

Countries citing papers authored by E. Grant Hoyt

Since Specialization
Citations

This map shows the geographic impact of E. Grant Hoyt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Grant Hoyt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Grant Hoyt more than expected).

Fields of papers citing papers by E. Grant Hoyt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Grant Hoyt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Grant Hoyt. The network helps show where E. Grant Hoyt may publish in the future.

Co-authorship network of co-authors of E. Grant Hoyt

This figure shows the co-authorship network connecting the top 25 collaborators of E. Grant Hoyt. A scholar is included among the top collaborators of E. Grant Hoyt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Grant Hoyt. E. Grant Hoyt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lijkwan, M.A., David T. Cooke, Jasper M. Martens, et al.. (2005). Cyclosporine treatment of high dose and long duration reduces the severity of graft coronary artery disease in rodent cardiac allografts. The Journal of Heart and Lung Transplantation. 24(4). 439–445. 7 indexed citations
2.
Cooke, David T., E. Grant Hoyt, & Robert C. Robbins. (2005). Overexpression of Human Bcl-2 in Syngeneic Rat Donor Lungs Preserves Posttransplant Function and Reduces Intragraft Caspase Activity and Interleukin-1?? Production. Transplantation. 79(7). 762–767. 14 indexed citations
3.
Balsam, Leora B., Sophie Jones, E. Grant Hoyt, et al.. (2005). Early Inhibition of Caspase-3 Activity Lessens the Development of Graft Coronary Artery Disease. The Journal of Heart and Lung Transplantation. 24(7). 827–832. 10 indexed citations
4.
Miniati, Douglas N., M.A. Lijkwan, Seiichiro Murata, et al.. (2003). Effects of adenoviral up-regulation of bcl-2 on oxidative stress and graft coronary artery disease in rat heart transplants. Transplantation. 76(2). 382–386. 10 indexed citations
5.
Yamaguchi, Atsushi, Douglas N. Miniati, Ken‐ichi Hirata, E. Grant Hoyt, & Robert C. Robbins. (2002). Ex vivo blockade of endothelin-1 inhibits graft coronary artery disease in a rodent cardiac allograft model. The Journal of Heart and Lung Transplantation. 21(4). 417–424. 15 indexed citations
6.
Grünenfelder, Jürg, Douglas N. Miniati, Seiichiro Murata, et al.. (2002). Up-regulation of Bcl-2 through hyperbaric pressure transfection of TGF-β1 ameliorates ischemia-reperfusion injury in rat cardiac allografts. The Journal of Heart and Lung Transplantation. 21(2). 244–250. 16 indexed citations
7.
Grünenfelder, Jürg, Doug Miniati, Shigeo Murata, et al.. (2001). Upregulation of Bcl-2 Through Caspase-3 Inhibition Ameliorates Ischemia/Reperfusion Injury in Rat Cardiac Allografts. Circulation. 104(suppl 1). I–202. 68 indexed citations
8.
Miniati, Doug, Jürg Grünenfelder, E. Grant Hoyt, et al.. (2001). Oxidative stress of cardiac transplantation is associated with decreased BCL-2 expression and increased NFKB activity. The Journal of Heart and Lung Transplantation. 20(2). 158–159. 7 indexed citations
9.
Feeley, Brian T., et al.. (2000). NUCLEAR FACTOR-??B TRANSCRIPTION FACTOR DECOY TREATMENT INHIBITS GRAFT CORONARY ARTERY DISEASE AFTER CARDIAC TRANSPLANTATION IN RODENTS1. Transplantation. 70(11). 1560–1568. 26 indexed citations
10.
Miniati, Doug, et al.. (2000). Ex Vivo Antisense Oligonucleotides to Proliferating Cell Nuclear Antigen and Cdc2 Kinase Inhibit Graft Coronary Artery Disease. Circulation. 102(Supplement 3). III–237. 17 indexed citations
11.
Poston, Robert S., Margaret E. Billingham, E. Grant Hoyt, et al.. (1999). Rapamycin Reverses Chronic Graft Vascular Disease in a Novel Cardiac Allograft Model. Circulation. 100(1). 67–74. 129 indexed citations
12.
Mann, Michael J., Gary H. Gibbons, Howard G. Hutchinson, et al.. (1999). Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues. Proceedings of the National Academy of Sciences. 96(11). 6411–6416. 98 indexed citations
13.
14.
Feeley, Brian T., et al.. (1999). Sulfasalazine inhibits reperfusion injury and prolongs allograft survival in rat cardiac transplants. The Journal of Heart and Lung Transplantation. 18(11). 1088–1095. 17 indexed citations
15.
Poston, Robert, Margaret E. Billingham, Jeffrey D. Pollard, E. Grant Hoyt, & Robert C. Robbins. (1997). Effects of Increased ICAM-1 on Reperfusion Injury and Chronic Graft Vascular Disease. The Annals of Thoracic Surgery. 64(4). 1004–1012. 38 indexed citations
16.
Hissink, R.J., et al.. (1995). IN VIVO STUDIES OF THE MAINTENANCE OF PERIPHERAL TRANSPLANT TOLERANCE AFTER CYCLOSPORINE. Transplantation. 59(10). 1444–1452. 14 indexed citations
17.
Vriens, Patrick W., et al.. (1994). TISSUE-SPECIFIC DIFFERENCES IN THE ESTABLISHMENT OF TOLERANCE. Transplantation. 57(12). 1795–1798. 13 indexed citations
18.
Shizuru, Judith A., Karl B. Seydel, Thomas F. Flavin, et al.. (1990). INDUCTION OF DONOR-SPECIFIC UNRESPONSIVENESS TO CARDIAC ALLOGRAFTS IN RATS BY PRETRANSPLANT ANTI-CD4 MONOCLONAL ANTIBODY THERAPY. Transplantation. 50(3). 366–373. 98 indexed citations
19.
Morris, Randall E., E. Grant Hoyt, Michael P. Murphy, Elsie M. Eugui, & A. C. Allison. (1990). Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis.. PubMed. 22(4). 1659–62. 145 indexed citations
20.
Prop, Jochum, E. Grant Hoyt, & Stuart W. Jamieson. (1987). (Nva2)-CYCLOSPORINE-LESS POTENT THAN CYCLOSPORINE A IN RATS WITH LUNG AND HEART TRANSPLANTS1. Transplantation. 44(1). 5–8. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nozomi Koyamada Breakdown of academic impact, for papers by Rafia S. Al‐Lamki Breakdown of academic impact, for papers by G R Bicknell Breakdown of academic impact, for papers by Kazuaki Nakajima Breakdown of academic impact, for papers by Nepal C. Chowdhury Breakdown of academic impact, for papers by Paul Hechenleitner Breakdown of academic impact, for papers by Günter Weigel Breakdown of academic impact, for papers by Huifang Chen Breakdown of academic impact, for papers by Hongsi Jiang Breakdown of academic impact, for papers by S. Yamamoto
Rankless by CCL
2026